首页> 外文期刊>Biochimica et Biophysica Acta. Molecular and cell biology of Lipids >Detection of the steroidogenic acute regulatory protein, StAR, in human liver cells
【24h】

Detection of the steroidogenic acute regulatory protein, StAR, in human liver cells

机译:检测人肝细胞中类固醇生成的急性调节蛋白StAR

获取原文
获取原文并翻译 | 示例
           

摘要

Overexpressing StAR (a mitochondrial cholesterol transporter) increases (> 5-fold) the rate of 27-hydroxylation of cholesterol and the rates of bile acid synthesis in primary rat hepatocytes; suggesting that the transport of cholesterol into mitochondria is rate-limiting for bile acid biosynthesis via the CYP27A1 initiated 'acidic' pathway Our objective was to determine the level of StAR expression in human liver and whether changes in StAR would correlate with changes in CYP27A1 activity/bile acid synthesis rates in human liver tissues. StAR mRNA and protein were detected in primary human hepatocytes and HepG2 cells by RT-PCR/Northern analysis and by Western analysis, respectively. In immunocompetition assays, liver StAR was competed away with the addition of purified human adrenal StAR. Overexpressing CYP27A1 in both cell types led to > 2-fold increases in liver StAR concentration. StAR protein levels also increased ∼ 2-fold with the addition of 27-hydroxycholesterol to HepG2 cell culture medium. Overexpressing StAR increased the rates of 27-hydroxylation of cholesterol/bile acid synthesis in both cell lines and increased intracellular levels of 27-hydroxycholesterol. In conclusion, human liver cells contain regulable StAR protein whose level of expression appears capable of regulating cellular cholesterol homeostasis, representing a potential therapeutic target in the management of hyperlipidemia. © 2005 Elsevier B.V. All rights reserved.
机译:过表达的StAR(线粒体胆固醇转运蛋白)可增加(> 5倍)胆固醇的27-羟基化速率和原代大鼠肝细胞胆汁酸合成速率;提示胆固醇通过CYP27A1启动的``酸性''途径向胆汁酸生物合成的速率限制是线粒体。我们的目标是确定人类肝脏中StAR的表达水平以及StAR的变化是否与CYP27A1活性的变化相关/人肝组织中胆汁酸的合成速率。通过RT-PCR / Northern分析和Western分析分别在原代人肝细胞和HepG2细胞中检测到StAR mRNA和蛋白。在免疫竞争测定中,肝脏StAR与添加纯化的人肾上腺StAR竞争。在两种细胞类型中过表达CYP27A1均导致>肝脏StAR浓度增加2倍。 StAR蛋白水平也增加了。向HepG2细胞培养基中添加27-羟基胆固醇的2倍。过表达的StAR增加了两种细胞系中胆固醇/胆汁酸合成的27-羟基化速率,并增加了27-羟基胆固醇的细胞内水平。总之,人类肝细胞含有可调节的StAR蛋白,其表达水平似乎能够调节细胞胆固醇的稳态,代表高脂血症管理中的潜在治疗靶标。 &复制; 2005 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号